S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
S&P 500   4,198.95 (-0.15%)
DOW   32,945.84 (-0.45%)
QQQ   350.41 (+0.58%)
AAPL   177.51 (+1.19%)
MSFT   332.21 (-0.20%)
META   264.43 (+0.91%)
GOOGL   123.49 (-0.90%)
AMZN   121.48 (+1.14%)
TSLA   198.92 (+2.98%)
NVDA   401.25 (+3.03%)
NIO   7.36 (-4.42%)
BABA   78.29 (-3.31%)
AMD   126.10 (-0.73%)
T   15.66 (+1.03%)
F   12.60 (+4.22%)
MU   72.48 (-1.96%)
CGC   0.87 (-0.95%)
GE   102.11 (-0.61%)
DIS   87.34 (-1.08%)
AMC   4.59 (-1.08%)
PFE   37.00 (-1.60%)
PYPL   61.19 (+1.61%)
NFLX   391.56 (+3.35%)
CVE:IGX

IntelGenx Technologies (IGX) Stock Forecast, Price & News

C$0.58
+0.01 (+1.75%)
(As of 10/6/2021)
Compare
Today's Range
C$0.58
▼
C$0.60
50-Day Range
C$0.58
▼
C$0.58
52-Week Range
C$0.17
▼
C$0.85
Volume
11,848 shs
Average Volume
56,279 shs
Market Capitalization
C$87.32 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsInsider TradesHeadlines

IGX stock logo

About IntelGenx Technologies (CVE:IGX) Stock

IntelGenx Technologies Corp., a drug delivery company, focuses on the development and manufacturing of novel oral thin film products for the pharmaceutical market. It offers INT0008/2008, a Rizatriptan oral film product for the treatment of migraine. The company's products under development comprise INT0004/2006, an antidepressant; INT0046/2018 for adult use; INT0007/2006 for the treatment of erectile dysfunction; INT0010/2006 for the treatment of neuropathic pain and nausea in cancer patients; INT0027/2011 to treat opioid addition; INT0036/2013 for schizophrenia; and INT0043/2015 to treat Alzheimer's disease; and INT0048/2020 for animal health. It is also developing INT0039/2013, INT0040/2014, INT0052/2020, and INT0053/2020. The company has licensing, development, and supply agreement with Tilray, Inc. and Gensco Pharma; and development agreement with Cynapsus Therapeutics Inc. IntelGenx Technologies Corp. was founded in 2003 and is headquartered in Montreal, Canada.

Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

IGX Stock News Headlines

May 11, 2023 | marketwatch.com
8-K: IntelGenx Technologies Corp.
April 27, 2023 | finance.yahoo.com
IntelGenx Extends Period to Exercise Certain Warrants
May 30, 2023 | Edge On The Street (Ad)
New "Mined in America" Lithium Opportunities?
The average electric vehicle needs 138 pounds of lithium carbonate for its battery components. But China currently controls the entire lithium supply chain.
April 27, 2023 | finance.yahoo.com
IntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal Film
April 20, 2023 | theglobeandmail.com
Closing Bell: Intelgenx Technologies Corp up on Wednesday (IGX)
April 17, 2023 | theglobeandmail.com
Closing Bell: Intelgenx Technologies Corp down on Monday (IGX)
April 15, 2023 | theglobeandmail.com
Closing Bell: Intelgenx Technologies Corp up on Friday (IGX)
April 13, 2023 | finance.yahoo.com
IntelGenx Announces Organizational Changes to Support Global Growth Strategy
May 30, 2023 | Edge On The Street (Ad)
The Graphite Shortage Story You're Not Being Told
Graphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security.
April 9, 2023 | theglobeandmail.com
Closing Bell: Intelgenx Technologies Corp WT flat on Thursday (IGX-WT)
March 29, 2023 | finance.yahoo.com
IntelGenx Reports Fourth Quarter and Full-Year 2022 Financial Results
March 24, 2023 | finance.yahoo.com
IntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023
March 23, 2023 | finance.yahoo.com
IntelGenx to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 – Conference Call to Follow
March 9, 2023 | finance.yahoo.com
IntelGenx to Participate in the 35th Annual Roth Conference
March 9, 2023 | finance.yahoo.com
CORRECTION – IntelGenx to Participate in the 35th Annual Roth Conference
February 16, 2023 | ca.finance.yahoo.com
IntelGenx Technologies Corp. (IGX.TO)
February 13, 2023 | finance.yahoo.com
IIROC Trading Halt - IGX.WT
January 15, 2023 | msn.com
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
January 9, 2023 | finance.yahoo.com
IntelGenx Receives Fourth and Final Loan Tranche from atai
November 10, 2022 | finance.yahoo.com
IntelGenx Reports Third Quarter 2022 Financial Results
November 9, 2022 | finance.yahoo.com
IntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm™
October 20, 2022 | finance.yahoo.com
IntelGenx Announces Issuance of New U.S. Patent Covering VersaFilm® Technology
October 18, 2022 | finance.yahoo.com
IntelGenx Submits Response to CRL from FDA for RIZAPORT® VersaFilm®
September 20, 2022 | it.tmcnet.com
NVIDIA Launches IGX Edge AI Computing Platform for Safe, Secure Autonomous Systems
September 8, 2022 | finance.yahoo.com
IntelGenx Announces Enrollment Reaches Halfway Mark in ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s Disease
August 11, 2022 | finance.yahoo.com
IntelGenx Reports Second Quarter 2022 Financial Results
August 4, 2022 | ca.finance.yahoo.com
Stocks in play: IntelGenx Technologies Corp.
See More Headlines
Receive IGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IntelGenx Technologies and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
CVE:IGX
CUSIP
N/A
CIK
N/A
Web
www.intelgenx.com
Phone
514-331-7440
Fax
N/A
Employees
48
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
164.62
Current Ratio
2.77
Quick Ratio
2.69

Sales & Book Value

Annual Sales
C$1.75 million
Price / Sales
49.95
Cash Flow
C$0.08 per share
Price / Cash Flow
7.16
Book Value
C$0.05 per share
Price / Book
12.89

Miscellaneous

Outstanding Shares
150,546,000
Free Float
N/A
Market Cap
C$87.32 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Dr. Horst G. Zerbe (Age 74)
    Chairman, CEO & Chairman of Scientific Advisory Board
    Comp: $240.75k
  • Mr. André Godin C.A. (Age 57)
    CPA, CPA, CA, Pres & CFO
    Comp: $223.6k
  • Ms. Nadine Paiement (Age 44)
    Vice-Chair of Scientific Advisory Board and VP of R&D - IntelGenx Corp
    Comp: $140.13k
  • Dr. Dana Matzen (Age 43)
    VP of Bus. & Corp. Devel. of IntelGenx Corp
    Comp: $171.43k
  • Stephen Kilmer
    Investor Relations Officer
  • Dr. Rodolphe Obeid Ph.D. (Age 41)
    VP of Operations - IntelGenx Corp
  • Mr. Tommy Kenny J.D. (Age 34)
    L.L.B., M.Sc., VP of Intellectual Property & Legal Affairs and Gen. Counsel of IntelGenx Corp
  • Ms. Ingrid Zerbe (Age 67)
    Corp. Sec.

Key Competitors

View All Competitors

Insiders

View All Insider Transactions













IGX Stock - Frequently Asked Questions

How have IGX shares performed in 2023?

IntelGenx Technologies' stock was trading at C$0.58 at the beginning of the year. Since then, IGX stock has increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2023 here.

What other stocks do shareholders of IntelGenx Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IntelGenx Technologies investors own include IntelGenx Technologies (IGXT), Aurora Cannabis (ACB), New Age Brands (NF), Capstone Copper (CS), Hanesbrands (HBI), Tilray (TLRY), ACADIA Pharmaceuticals (ACAD), AusCann Group (AC8), Cameco (CCJ) and Baylin Technologies (BYL).

What is IntelGenx Technologies' stock symbol?

IntelGenx Technologies trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGX."

How do I buy shares of IntelGenx Technologies?

Shares of IGX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is IntelGenx Technologies' stock price today?

One share of IGX stock can currently be purchased for approximately C$0.58.

How much money does IntelGenx Technologies make?

IntelGenx Technologies (CVE:IGX) has a market capitalization of C$87.32 million and generates C$1.75 million in revenue each year.

How can I contact IntelGenx Technologies?

The official website for the company is www.intelgenx.com. The company can be reached via phone at 514-331-7440.

This page (CVE:IGX) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -